Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryce Chackerian

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Expert Review of Vaccines|June 5, 2007
Virus-like particles: flexible platforms for vaccine developmentBryce Chackerian
Human Vaccines|September 25, 2010
Virus-like particle based vaccines for Alzheimer diseaseBryce Chackerian
Expert Review of Vaccines|September 17, 2011
Genital delivery of virus-like particle and pseudovirus-based vaccinesNicolas Cuburu, Bryce Chackerian
Current Opinion in Lipidology|July 9, 2016
Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9Bryce Chackerian, Alan Remaley
Plos Pathogens|August 8, 2014
Why HIV virions have low numbers of envelope spikes: implications for vaccine developmentJohn Schiller, Bryce Chackerian
Viruses|January 16, 2020
Factors That Govern the Induction of Long-Lived Antibody ResponsesBryce Chackerian, David S Peabody
Expert Review of Vaccines|February 27, 2016
Moving towards a new class of vaccines for non-infectious chronic diseasesBryce Chackerian, Kathryn M Frietze
Journal of Lipid Research|February 19, 2024
PCSK9 vaccines: a promising new strategy for the treatment of hypercholesterolemia?Bryce Chackerian, Alan T Remaley
Expert Review of Vaccines|December 20, 2013
Second-generation prophylactic HPV vaccines: successes and challengesMitchell Tyler, Ebenezer Tumban, Bryce Chackerian
Expert Review of Vaccines|October 10, 2018
Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatisKathryn M Frietze, Rebeccah Lijek, Bryce Chackerian
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Expert Review of Vaccines|June 5, 2007
Virus-like particles: flexible platforms for vaccine developmentBryce Chackerian
Human Vaccines|September 25, 2010
Virus-like particle based vaccines for Alzheimer diseaseBryce Chackerian
Expert Review of Vaccines|September 17, 2011
Genital delivery of virus-like particle and pseudovirus-based vaccinesNicolas Cuburu, Bryce Chackerian
Current Opinion in Lipidology|July 9, 2016
Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9Bryce Chackerian, Alan Remaley
Plos Pathogens|August 8, 2014
Why HIV virions have low numbers of envelope spikes: implications for vaccine developmentJohn Schiller, Bryce Chackerian
Viruses|January 16, 2020
Factors That Govern the Induction of Long-Lived Antibody ResponsesBryce Chackerian, David S Peabody
Expert Review of Vaccines|February 27, 2016
Moving towards a new class of vaccines for non-infectious chronic diseasesBryce Chackerian, Kathryn M Frietze
Journal of Lipid Research|February 19, 2024
PCSK9 vaccines: a promising new strategy for the treatment of hypercholesterolemia?Bryce Chackerian, Alan T Remaley
Expert Review of Vaccines|December 20, 2013
Second-generation prophylactic HPV vaccines: successes and challengesMitchell Tyler, Ebenezer Tumban, Bryce Chackerian
Expert Review of Vaccines|October 10, 2018
Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatisKathryn M Frietze, Rebeccah Lijek, Bryce Chackerian
Pageof 10